14.12.2022
PRICE INQUIRY No. 19 - being conducted as a market assessment study - amendment to the content - cancelled
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
25.11.2022
PRICE INQUIRY No. 18 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
23.11.2022
PRICE INQUIRY No. 13 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
18.10.2022
PRICE INQUIRY No. 9 - being conducted as a market assessment study - cancelled
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
22.08.2022
PRICE INQUIRY No. 8 - being conducted as a market assessment study
In connection with the project titled: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, co-funded…
30.06.2022
PRICE INQUIRY No. 7 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
Polpharma Group
We are the largest Polish manufacturer of pharmaceuticals and a leader of the…
read more